Fierce Biotech Homepage

Naoki Okamura
Pharma

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

With Xtandi set to lose U.S. patent protection next year, Astellas’ CEO fielded questions this week about his company’s BD strategy ahead of the loss.
Angus Liu Jan 15, 2026 10:42am
Union Square in San Francisco during JPM 2026
Favicon Fierce Biotech

JPM26: Sanofi looks ahead to lingering US policy hurdles

Jan 14, 2026 2:28pm
Abstract purple and magenta ribbon-like design layered over a collage of black-and-white portraits of Fierce 50 honorees in h

Fierce 50 of 2025

Brought to you by Finn Partners
Gilead Sciences Women HIV Movement campaign
Favicon Fierce Biotech

JPM26: Gilead eyes new deals from a 'position of strength'

Jan 14, 2026 3:30am
Leo

JPM26: Leo Pharma sharpens its eye for dermatology dealmaking

Jan 13, 2026 2:45pm
Boerner

Bristol Myers CEO pledges to 'cast a broad net' in dealmaking

Jan 12, 2026 4:28pm
More News
Fierce Biotech

Vertex passes neuropathic pain test, teeing up pivotal trials

Dec 13, 2023 7:52am
Fierce Biotech

Sofinnova opens biotech creation ‘toolbox’ for Europe strategy

Dec 13, 2023 9:20am
Fierce Biotech

First-ever drug application for MDMA finally reaches FDA

Dec 13, 2023 9:39am
Fierce Biotech

Tandem begins full U.S. rollout of diabetes management platform

Dec 13, 2023 10:14am